Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy
Journal Article
·
· Circulation; (United States)
We examined the uptake and release of norepinephrine in the cardiac circulation and other regional vascular beds in 11 patients with hypertrophic cardiomyopathy (HCM) and in 10 control subjects during simultaneous infusion of tracer-labeled norepinephrine and isoproterenol. Cardiac neuronal uptake of norepinephrine was assessed by comparing regional removal of tracer-labeled norepinephrine with that of tracer-labeled isoproterenol (which is not a substrate for neuronal uptake) and by the relation between production of dihydroxyphenylglycol (DHPG), an exclusively intraneuronal metabolite of norepinephrine, and regional spillover of norepinephrine. Cardiac extraction of norepinephrine averaged 59 +/- 17% in the patients with HCM, significantly less than in the control subjects (79 +/- 13%, p less than 0.05), whereas cardiac extraction of isoproterenol was similar in the two groups (13 +/- 23% versus 13 +/- 14%), indicating that neuronal uptake of norepinephrine was decreased in the patients with HCM. The cardiac arteriovenous difference in norepinephrine was significantly larger in the patients with HCM than in the control subjects (73 +/- 77 versus 13 +/- 50 pg/ml, p less than 0.05), as was the product of the arteriovenous difference in norepinephrine and coronary blood flow (7.3 +/- 7.3 versus 0.8 +/- 3.0 ng/min, p less than 0.05).
- Research Organization:
- National Heart, Lung, and Blood Institute, Bethesda, MD (USA)
- OSTI ID:
- 6150150
- Journal Information:
- Circulation; (United States), Journal Name: Circulation; (United States) Vol. 79:4; ISSN CIRCA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Quantitative analysis of sup 123 I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy
Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography
Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches
Journal Article
·
Fri Jun 01 00:00:00 EDT 1990
· American Heart Journal; (USA)
·
OSTI ID:6697541
Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography
Journal Article
·
Thu Mar 14 23:00:00 EST 1991
· Journal of the American College of Cardiology; (USA)
·
OSTI ID:5919550
Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches
Journal Article
·
Thu Aug 15 00:00:00 EDT 2019
· Current Cardiology Reports (Print)
·
OSTI ID:22929219
Related Subjects
550901* -- Pathology-- Tracer Techniques
59 BASIC BIOLOGICAL SCIENCES
ADRENAL HORMONES
ALCOHOLS
ANIMAL CELLS
AUTONOMIC NERVOUS SYSTEM AGENTS
BIOCHEMICAL REACTION KINETICS
BLOOD FLOW
BODY
CARDIOTONICS
CARDIOVASCULAR AGENTS
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
DISEASES
DRUGS
GLYCOLS
HEART
HYDROXY COMPOUNDS
ISOTOPE APPLICATIONS
KINETICS
LABELLED COMPOUNDS
MUSCLES
MYOCARDIUM
NERVE CELLS
NEUROREGULATORS
NORADRENALINE
ORGANIC COMPOUNDS
ORGANS
PATHOGENESIS
PATIENTS
REACTION KINETICS
SOMATIC CELLS
SYMPATHOMIMETICS
TRACER TECHNIQUES
TRITIUM COMPOUNDS
59 BASIC BIOLOGICAL SCIENCES
ADRENAL HORMONES
ALCOHOLS
ANIMAL CELLS
AUTONOMIC NERVOUS SYSTEM AGENTS
BIOCHEMICAL REACTION KINETICS
BLOOD FLOW
BODY
CARDIOTONICS
CARDIOVASCULAR AGENTS
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
DISEASES
DRUGS
GLYCOLS
HEART
HYDROXY COMPOUNDS
ISOTOPE APPLICATIONS
KINETICS
LABELLED COMPOUNDS
MUSCLES
MYOCARDIUM
NERVE CELLS
NEUROREGULATORS
NORADRENALINE
ORGANIC COMPOUNDS
ORGANS
PATHOGENESIS
PATIENTS
REACTION KINETICS
SOMATIC CELLS
SYMPATHOMIMETICS
TRACER TECHNIQUES
TRITIUM COMPOUNDS